MARKERS OF EXTRACELLULAR MATRIX TURNOVER AND RISK OF DEATH IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS FROM I-PRESERVE

被引:2
|
作者
Chow, Sheryl L. [1 ]
Krum, Henry [1 ]
O'Barr, Stephen A. [1 ]
Zile, Michael [1 ]
Carson, Peter [1 ]
Komajda, Michel [1 ]
McMurray, John [1 ]
Anand, Inderjit [1 ]
机构
[1] Western Univ Hlth Sci, Pomona, CA USA
关键词
D O I
10.1016/S0735-1097(15)60969-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1216-192
引用
收藏
页码:A969 / A969
页数:1
相关论文
共 50 条
  • [21] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients with Heart Failure and Preserved Ejection Fraction: The I-PRESERVE Trial
    Lam, Carolyn S.
    Anand, Inder S.
    Carson, Peter E.
    Massie, Barry M.
    Rector, Thomas S.
    Kuskowski, Michael
    McKelvie, Robert S.
    Zile, Michael R.
    McMurray, John J.
    Komajda, Michel
    Kitzman, Dalane W.
    CIRCULATION, 2011, 124 (21)
  • [22] Relationship between pulse pressure and mortality in heart failure with preserved ejection fraction in the I-Preserve Trial
    Pozzi, A.
    Jhund, P. S.
    Carson, P. E.
    Komajda, M. R.
    Mckelvie, M. R.
    Zile, M. R.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 277 - 278
  • [23] Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
    Abdul-Rahim, Azmil H.
    Perez, Ana-Cristina
    MacIsaac, Rachael L.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Carson, Peter E.
    Komajda, Michel
    McKelvie, Robert S.
    Zile, Michael R.
    Swedberg, Karl
    Yusuf, Salim
    Pfeffer, Marc A.
    Solomon, Scott D.
    Lip, Gregory Y. H.
    Lees, Kennedy R.
    McMurray, John J. V.
    EUROPEAN HEART JOURNAL, 2017, 38 (10) : 742 - 750
  • [24] Predictors of outcome in heart failure with preserved ejection fraction: One year findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE)
    Carson, Peter E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A251 - A251
  • [25] Obesity and Its Relationship to Adverse Cardiovascular Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction in the I-PRESERVE Trial
    Kitzman, Dalane W.
    Haas, Marcus M.
    Carson, Peter E.
    Hetzel, Scott
    Komajda, Michael
    Zile, Michael
    Mckelvie, Robert
    Mcmurray, John J.
    Demets, D.
    Staiger, C.
    Ptaszynska, Agata
    Massie, Barry
    CIRCULATION, 2009, 120 (18) : S757 - S758
  • [26] PROGNOSTIC SIGNIFICANCE OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION PROGRESSION IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE I-PRESERVE TRIAL
    Russo, Cesare
    Jin, Chelsea
    Tao, Lin
    Desai, Kaushal
    Goshorn, Alice
    Donovan, Mark
    Ptaszynska, Agata
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 885 - 885
  • [27] Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF PEF). Findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE)
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Donovan, Mark
    Ptaszynska, Agatha
    Massie, Barry M.
    Carson, Peter
    CIRCULATION, 2007, 116 (16) : 551 - 551
  • [28] What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?
    Campbell, Ross T.
    Jhund, Pardeep S.
    Castagno, Davide
    Hawkins, Nathaniel M.
    Petrie, Mark C.
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (23) : 2349 - 2356
  • [29] PERIPHERAL COLLAGEN MARKERS PREDICT ALL-CAUSE MORTALITY AND CARDIOVASCULAR HOSPITALISATION IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION: RESULTS OF THE I-PRESERVE COLLAGEN SUB-STUDY
    Krum, Henry
    Elsik, Maros
    Schneider, Hans G.
    Ptaszynska, Agata
    Black, Marion
    Carson, Peter
    Massie, Barry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [30] Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction findings from the irbesartan in heart failure with preserved systolic function trial (I-PRESERVE)
    Zile, Michael R.
    Komajda, Michel
    McKelvie, Robert
    McMurray, John
    Donovan, Mark
    Ptaszynska, Agata
    Carson, Peter
    Massie, Barry M.
    CIRCULATION, 2007, 116 (16) : 706 - 707